Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015 von Galon, J, Fox, B A, Bifulco, C B, Masucci, G, Rau, T, Botti, G, Marincola, F M, Ciliberto, G, Pages, F, Ascierto, P A, Capone, M

Volltext

Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial von Ciardiello, F., Normanno, N., Maiello, E., Martinelli, E., Troiani, T., Pisconti, S., Giuliani, F., Barone, C., Cartenì, G., Rachiglio, A.M., Montesarchio, V., Tonini, G., Rizzi, D., Cinieri, S., Bordonaro, R., Febbraro, A., De Vita, F., Orditura, M., Fenizia, F., Lambiase, M., Rinaldi, A., Tatangelo, F., Botti, G., Colucci, G.

Volltext

Low doses of Bisphenol A have pro-inflammatory and pro-oxidant effects, stimulate lipid peroxidation and increase the cardiotoxicity of Doxorubicin in cardiomyoblasts von Quagliariello, V., Coppola, C., Mita, D.G., Piscopo, G., Iaffaioli, R.V., Botti, G., Maurea, N.

Volltext

Hydroxide-Induced Degradation of Olefin Metathesis Catalysts: A Challenge for Metathesis in Alkaline Media von Goudreault, Alexandre Y, Walden, Daniel M, Nascimento, Daniel L, Botti, Adrian G, Steinmann, Stephan N, Michel, Carine, Fogg, Deryn E

Volltext

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial von Normanno, N., Rachiglio, A.M., Lambiase, M., Martinelli, E., Fenizia, F., Esposito, C., Roma, C., Troiani, T., Rizzi, D., Tatangelo, F., Botti, G., Maiello, E., Colucci, G., Ciardiello, F., Giuliani, F., Simone, G., Febbraro, A., Tommaselli, E., Cinieri, S., Criscuolo, M., Perrino, A., Rinaldi, A., Bordonaro, R., Manusia, M., Romito, S., Bufo, P., Cartenì, G., Biglietto, M., Nappi, O., Cardarelli, A., Montesarchio, E., Micheli, P., Nasti, G., Chicchinelli, N., Iannaccone, A., Russo, A., Cabibi, D., Giaccone, P., Barone, C., Rindi, G., Tonini, G., Onetti Muda, A., Perrone, G., Latiano, T., Graziano, P., Pisconti, S., Sebastio, A.

Volltext

Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab von Quagliariello, V., Passariello, M., Coppola, C., Rea, D., Barbieri, A., Scherillo, M., Monti, M.G., Iaffaioli, R.V., De Laurentiis, M., Ascierto, P.A., Botti, G., De Lorenzo, C., Maurea, N.

Volltext

Prospective Monitoring of Polyomavirus BK Replication and Impact of Pre‐Emptive Intervention in Pediatric Kidney Recipients von Ginevri, F., Azzi, A., Hirsch, H. H., Basso, S., Fontana, I., Cioni, M., Bodaghi, S., Salotti, V., Rinieri, A., Botti, G., Perfumo, F., Locatelli, F., Comoli, P.

Volltext

The non-pathogenic Australian lagovirus RCV-A1 causes a prolonged infection and elicits partial cross-protection to rabbit haemorrhagic disease virus von Strive, T, Wright, J, Kovaliski, J, Botti, G, Capucci, L

Volltext

BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy von Colombino, M, Sperlongano, P, Izzo, F, Tatangelo, F, Botti, G, Lombardi, A, Accardo, M, Tarantino, L, Sordelli, I, Agresti, M, Abbruzzese, A, Caraglia, M, Palmieri, G

Volltext

CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells von Ieranò, C, Santagata, S, Napolitano, M, Guardia, F, Grimaldi, A, Antignani, E, Botti, G, Consales, C, Riccio, A, Nanayakkara, M, Barone, M V, Caraglia, M, Scala, S

Volltext

Midface Lift: Our Current Approaches von Botti, G., Botti, C.

Volltext

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial von Perrone, F., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Labonia, V., Landi, G., Pacilio, C., Rossi, E., De Laurentiis, M., D'Aiuto, M., Botti, G., Forestieri, V., Lauria, R., De Placido, S., Tinessa, V., Daniele, B., Gori, S., Colantuoni, G., Barni, S., Riccardi, F., De Maio, E., Montanino, A., Morabito, A., Daniele, G., Di Maio, M., Piccirillo, M.C., Signoriello, S., Gallo, C., de Matteis, A.

Volltext

Efficacy of two Ni-Ti systems and hand files for removing gutta-percha from root canals von Mollo, A., Botti, G., Prinicipi Goldoni, N., Randellini, E., Paragliola, R., Chazine, M., Ounsi, H. F., Grandini, S.

Volltext

Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort von Barba, M., Sperati, F., Stranges, S., Carlomagno, C., Nasti, G., Iaffaioli, V., Caolo, G., Mottolese, M., Botti, G., Terrenato, I., Vici, P., Serpico, D., Giordano, A., D’Aiuto, G., Crispo, A., Montella, M., Capurso, G., Delle Fave, G., Fuhrman, B., Botti, C., De Placido, S.

Volltext

WNT pathway in oral cancer: Epigenetic inactivation of WNT-inhibitors von PANNONE, G, BUFO, P, CARAGLIA, M, PAPAGERAKIS, S, LO MUZIO, L, SANTORO, A, FRANCO, R, AQUINO, G, LONGO, F, BOTTI, G, SERPICO, R, CAFARELLI, B, ABBRUZZESE, A

Volltext

Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes von Crispo, A., Augustin, L.S.A., Grimaldi, M., Nocerino, F., Giudice, A., Cavalcanti, E., Di Bonito, M., Botti, G., De Laurentiis, M., Rinaldo, M., Esposito, E., Riccardi, G., Amore, A., Libra, M., Ciliberto, G., Jenkins, D.J.A., Montella, M.

Volltext

Phase I/II study of valproic acid (VPA) and short-course radiotherapy (SCRT) plus capecitabine (CAP) as preoperative treatment in low-moderate risk rectal cancer (V-shoRT-R3) von Budillon, A, Delrio, P, Pecori, B, Tatangelo, F, Di Gennaro, E, Romano, C, D'Angelo, V, Marone, P, Granata, C, Cavalacanti, E, De Stefano, A, Pace, U, Bianco, F, Petrillo, A, Lastoria, S, Botti, G, Muto, P, Perrone, F, Piccirillo, M C, Avallone, A

Volltext

PATZ1 is a new prognostic marker of diffuse large B cell lymphomas von Franco, R, Scognamiglio, G, Valentino, E, Vitiello, M, Panico, L, Pinto, A, Botti, G, De Chiara, A, Cerchia, L, Fedele, M

Volltext

Expression and functional role of CRIPTO-1 in cutaneous melanoma von De Luca, A, Lamura, L, Strizzi, L, Roma, C, D'Antonio, A, Margaryan, N, Pirozzi, G, Hsu, M-Y, Botti, G, Mari, E, Hendrix, M J C, Salomon, D S, Normanno, N

Volltext

TERT promoter and CTNNB1 gene mutations represent cancer signatures specific for hepatitis B and hepatitis C related hepatocellular carcinoma von Pezzuto, F, Izzo, F, Buonaguro, L, Annunziata, C, Tatangelo, F, Botti, G, Buonaguro, F.M, Tornesello, M.L

Volltext